Utility of T2-weighted MRI to Differentiate Adrenal Metastases from Lipid-Poor Adrenal Adenomas
To evaluate T2-weighted MRI features to differentiate adrenal metastases from lipid-poor adenomas. With institutional review board approval, this study retrospectively compared 40 consecutive patients (mean age, 66 years ± 10 [standard deviation]) with metastases to 23 patients (mean age, 60 years ±...
Gespeichert in:
Veröffentlicht in: | Radiology. Imaging cancer 2020-11, Vol.2 (6), p.e200011-e200011 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | e200011 |
---|---|
container_issue | 6 |
container_start_page | e200011 |
container_title | Radiology. Imaging cancer |
container_volume | 2 |
creator | Tu, Wendy Abreu-Gomez, Jorge Udare, Amar Alrashed, Abdulmohsen Schieda, Nicola |
description | To evaluate T2-weighted MRI features to differentiate adrenal metastases from lipid-poor adenomas.
With institutional review board approval, this study retrospectively compared 40 consecutive patients (mean age, 66 years ± 10 [standard deviation]) with metastases to 23 patients (mean age, 60 years ± 15) with lipid-poor adenomas at 1.5- and 3-T MRI between June 2016 and March 2019. A blinded radiologist measured T2-weighted signal intensity (SI) ratio (SI
/SI
), T2-weighted histogram features, and chemical shift SI index. Two blinded radiologists (radiologist 1 and radiologist 2) assessed T2-weighted SI and T2-weighted heterogeneity using five-point Likert scales.
Subjectively, T2-weighted SI (
< .001 for radiologist 1 and radiologist 2) and T2-weighted heterogeneity (
< .001, for radiologist 1 and radiologist 2) were higher in metastases compared with adenomas when assessed by both radiologists. Agreement between the radiologists was substantial for T2-weighted SI (Cohen κ = 0.67) and T2-weighted heterogeneity (κ = 0.62). Metastases had higher T2-weighted SI ratio than adenomas (3.6 ± 1.7 [95% confidence interval {CI}: 0.2, 8.2] vs 2.2 ± 1.0 [95% CI: 0.6, 4.3],
< .001) and higher T2-weighted entropy (6.6 ± 0.6 [95% CI: 4.9, 7.5] vs 5.0 ± 0.8 [95% CI: 3.5, 6.6],
< .001). At multivariate analysis, T2-weighted entropy was the best differentiating feature (
<
001). Chemical shift SI index did not differ between metastases and adenomas (
= .748). Area under the receiver operating characteristic curve (AUC) for T2-weighted SI ratio and T2-weighted entropy were 0.76 (95% CI: 0.64, 0.88) and 0.94 (95% CI: 0.88, 0.99). The logistic regression model combining T2-weighted SI ratio with T2-weighted entropy yielded AUC of 0.95 (95% CI: 0.91, 0.99) and did not differ compared with T2-weighted entropy alone (
= .268). There was no difference in logistic regression model accuracy comparing the data by either field strength, 1.5- or 3-T MRI (
> .05).
Logistic regression models combining T2-weighted SI and T2-weighted heterogeneity can differentiate metastases from lipid-poor adenomas. Validation of these preliminary results is required.
Adrenal, MR-Imaging, Urinary
© RSNA, 2020. |
doi_str_mv | 10.1148/rycan.2020200011 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7983803</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2506513165</sourcerecordid><originalsourceid>FETCH-LOGICAL-c462t-8fb517c8b80ce5c4a2214962414d390aa5656578378e04f949997b6d8019e87c3</originalsourceid><addsrcrecordid>eNpVUVFLHDEQDqVSRX3vU8ljX1YzSTbJvhQO26pwohSFvoVcdlZTdjfXJNdy_949T0_lG5iB-b5vBj5CPgM7AZDmNK29G08424AxgA_kgCthKgXq98c38z45zvnPROGgARh8IvtCaG20NAfE3pXQh7KmsaO3vPqP4f6hYEuvfl3SEun30HWYcCzBFaSzdhpdT6-wuDwVZtqlONB5WIa2uokx7SizFsc4uHxE9jrXZzx-7ofk7ueP27OLan59fnk2m1deKl4q0y1q0N4sDPNYe-k4B9koLkG2omHO1WqCNkIbZLJrZNM0eqFaw6BBo704JN-2vsvVYsDWTy8n19tlCoNLaxtdsO83Y3iw9_Gf1Y0RhonJ4OuzQYp_V5iLHUL22PduxLjKltdM1SBA1ROVbak-xZwTdrszwOwmGvsUjX2NZpJ8efveTvAShHgE44qKmA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2506513165</pqid></control><display><type>article</type><title>Utility of T2-weighted MRI to Differentiate Adrenal Metastases from Lipid-Poor Adrenal Adenomas</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>Tu, Wendy ; Abreu-Gomez, Jorge ; Udare, Amar ; Alrashed, Abdulmohsen ; Schieda, Nicola</creator><creatorcontrib>Tu, Wendy ; Abreu-Gomez, Jorge ; Udare, Amar ; Alrashed, Abdulmohsen ; Schieda, Nicola</creatorcontrib><description>To evaluate T2-weighted MRI features to differentiate adrenal metastases from lipid-poor adenomas.
With institutional review board approval, this study retrospectively compared 40 consecutive patients (mean age, 66 years ± 10 [standard deviation]) with metastases to 23 patients (mean age, 60 years ± 15) with lipid-poor adenomas at 1.5- and 3-T MRI between June 2016 and March 2019. A blinded radiologist measured T2-weighted signal intensity (SI) ratio (SI
/SI
), T2-weighted histogram features, and chemical shift SI index. Two blinded radiologists (radiologist 1 and radiologist 2) assessed T2-weighted SI and T2-weighted heterogeneity using five-point Likert scales.
Subjectively, T2-weighted SI (
< .001 for radiologist 1 and radiologist 2) and T2-weighted heterogeneity (
< .001, for radiologist 1 and radiologist 2) were higher in metastases compared with adenomas when assessed by both radiologists. Agreement between the radiologists was substantial for T2-weighted SI (Cohen κ = 0.67) and T2-weighted heterogeneity (κ = 0.62). Metastases had higher T2-weighted SI ratio than adenomas (3.6 ± 1.7 [95% confidence interval {CI}: 0.2, 8.2] vs 2.2 ± 1.0 [95% CI: 0.6, 4.3],
< .001) and higher T2-weighted entropy (6.6 ± 0.6 [95% CI: 4.9, 7.5] vs 5.0 ± 0.8 [95% CI: 3.5, 6.6],
< .001). At multivariate analysis, T2-weighted entropy was the best differentiating feature (
<
001). Chemical shift SI index did not differ between metastases and adenomas (
= .748). Area under the receiver operating characteristic curve (AUC) for T2-weighted SI ratio and T2-weighted entropy were 0.76 (95% CI: 0.64, 0.88) and 0.94 (95% CI: 0.88, 0.99). The logistic regression model combining T2-weighted SI ratio with T2-weighted entropy yielded AUC of 0.95 (95% CI: 0.91, 0.99) and did not differ compared with T2-weighted entropy alone (
= .268). There was no difference in logistic regression model accuracy comparing the data by either field strength, 1.5- or 3-T MRI (
> .05).
Logistic regression models combining T2-weighted SI and T2-weighted heterogeneity can differentiate metastases from lipid-poor adenomas. Validation of these preliminary results is required.
Adrenal, MR-Imaging, Urinary
© RSNA, 2020.</description><identifier>ISSN: 2638-616X</identifier><identifier>EISSN: 2638-616X</identifier><identifier>DOI: 10.1148/rycan.2020200011</identifier><identifier>PMID: 33778748</identifier><language>eng</language><publisher>United States: Radiological Society of North America</publisher><subject>Original Research</subject><ispartof>Radiology. Imaging cancer, 2020-11, Vol.2 (6), p.e200011-e200011</ispartof><rights>2020 by the Radiological Society of North America, Inc.</rights><rights>2020 by the Radiological Society of North America, Inc. 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c462t-8fb517c8b80ce5c4a2214962414d390aa5656578378e04f949997b6d8019e87c3</citedby><cites>FETCH-LOGICAL-c462t-8fb517c8b80ce5c4a2214962414d390aa5656578378e04f949997b6d8019e87c3</cites><orcidid>0000-0002-2653-4786 ; 0000-0002-9442-7536</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7983803/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7983803/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,724,777,781,882,27905,27906,53772,53774</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33778748$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tu, Wendy</creatorcontrib><creatorcontrib>Abreu-Gomez, Jorge</creatorcontrib><creatorcontrib>Udare, Amar</creatorcontrib><creatorcontrib>Alrashed, Abdulmohsen</creatorcontrib><creatorcontrib>Schieda, Nicola</creatorcontrib><title>Utility of T2-weighted MRI to Differentiate Adrenal Metastases from Lipid-Poor Adrenal Adenomas</title><title>Radiology. Imaging cancer</title><addtitle>Radiol Imaging Cancer</addtitle><description>To evaluate T2-weighted MRI features to differentiate adrenal metastases from lipid-poor adenomas.
With institutional review board approval, this study retrospectively compared 40 consecutive patients (mean age, 66 years ± 10 [standard deviation]) with metastases to 23 patients (mean age, 60 years ± 15) with lipid-poor adenomas at 1.5- and 3-T MRI between June 2016 and March 2019. A blinded radiologist measured T2-weighted signal intensity (SI) ratio (SI
/SI
), T2-weighted histogram features, and chemical shift SI index. Two blinded radiologists (radiologist 1 and radiologist 2) assessed T2-weighted SI and T2-weighted heterogeneity using five-point Likert scales.
Subjectively, T2-weighted SI (
< .001 for radiologist 1 and radiologist 2) and T2-weighted heterogeneity (
< .001, for radiologist 1 and radiologist 2) were higher in metastases compared with adenomas when assessed by both radiologists. Agreement between the radiologists was substantial for T2-weighted SI (Cohen κ = 0.67) and T2-weighted heterogeneity (κ = 0.62). Metastases had higher T2-weighted SI ratio than adenomas (3.6 ± 1.7 [95% confidence interval {CI}: 0.2, 8.2] vs 2.2 ± 1.0 [95% CI: 0.6, 4.3],
< .001) and higher T2-weighted entropy (6.6 ± 0.6 [95% CI: 4.9, 7.5] vs 5.0 ± 0.8 [95% CI: 3.5, 6.6],
< .001). At multivariate analysis, T2-weighted entropy was the best differentiating feature (
<
001). Chemical shift SI index did not differ between metastases and adenomas (
= .748). Area under the receiver operating characteristic curve (AUC) for T2-weighted SI ratio and T2-weighted entropy were 0.76 (95% CI: 0.64, 0.88) and 0.94 (95% CI: 0.88, 0.99). The logistic regression model combining T2-weighted SI ratio with T2-weighted entropy yielded AUC of 0.95 (95% CI: 0.91, 0.99) and did not differ compared with T2-weighted entropy alone (
= .268). There was no difference in logistic regression model accuracy comparing the data by either field strength, 1.5- or 3-T MRI (
> .05).
Logistic regression models combining T2-weighted SI and T2-weighted heterogeneity can differentiate metastases from lipid-poor adenomas. Validation of these preliminary results is required.
Adrenal, MR-Imaging, Urinary
© RSNA, 2020.</description><subject>Original Research</subject><issn>2638-616X</issn><issn>2638-616X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNpVUVFLHDEQDqVSRX3vU8ljX1YzSTbJvhQO26pwohSFvoVcdlZTdjfXJNdy_949T0_lG5iB-b5vBj5CPgM7AZDmNK29G08424AxgA_kgCthKgXq98c38z45zvnPROGgARh8IvtCaG20NAfE3pXQh7KmsaO3vPqP4f6hYEuvfl3SEun30HWYcCzBFaSzdhpdT6-wuDwVZtqlONB5WIa2uokx7SizFsc4uHxE9jrXZzx-7ofk7ueP27OLan59fnk2m1deKl4q0y1q0N4sDPNYe-k4B9koLkG2omHO1WqCNkIbZLJrZNM0eqFaw6BBo704JN-2vsvVYsDWTy8n19tlCoNLaxtdsO83Y3iw9_Gf1Y0RhonJ4OuzQYp_V5iLHUL22PduxLjKltdM1SBA1ROVbak-xZwTdrszwOwmGvsUjX2NZpJ8efveTvAShHgE44qKmA</recordid><startdate>20201101</startdate><enddate>20201101</enddate><creator>Tu, Wendy</creator><creator>Abreu-Gomez, Jorge</creator><creator>Udare, Amar</creator><creator>Alrashed, Abdulmohsen</creator><creator>Schieda, Nicola</creator><general>Radiological Society of North America</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-2653-4786</orcidid><orcidid>https://orcid.org/0000-0002-9442-7536</orcidid></search><sort><creationdate>20201101</creationdate><title>Utility of T2-weighted MRI to Differentiate Adrenal Metastases from Lipid-Poor Adrenal Adenomas</title><author>Tu, Wendy ; Abreu-Gomez, Jorge ; Udare, Amar ; Alrashed, Abdulmohsen ; Schieda, Nicola</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c462t-8fb517c8b80ce5c4a2214962414d390aa5656578378e04f949997b6d8019e87c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Original Research</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tu, Wendy</creatorcontrib><creatorcontrib>Abreu-Gomez, Jorge</creatorcontrib><creatorcontrib>Udare, Amar</creatorcontrib><creatorcontrib>Alrashed, Abdulmohsen</creatorcontrib><creatorcontrib>Schieda, Nicola</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Radiology. Imaging cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tu, Wendy</au><au>Abreu-Gomez, Jorge</au><au>Udare, Amar</au><au>Alrashed, Abdulmohsen</au><au>Schieda, Nicola</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Utility of T2-weighted MRI to Differentiate Adrenal Metastases from Lipid-Poor Adrenal Adenomas</atitle><jtitle>Radiology. Imaging cancer</jtitle><addtitle>Radiol Imaging Cancer</addtitle><date>2020-11-01</date><risdate>2020</risdate><volume>2</volume><issue>6</issue><spage>e200011</spage><epage>e200011</epage><pages>e200011-e200011</pages><issn>2638-616X</issn><eissn>2638-616X</eissn><abstract>To evaluate T2-weighted MRI features to differentiate adrenal metastases from lipid-poor adenomas.
With institutional review board approval, this study retrospectively compared 40 consecutive patients (mean age, 66 years ± 10 [standard deviation]) with metastases to 23 patients (mean age, 60 years ± 15) with lipid-poor adenomas at 1.5- and 3-T MRI between June 2016 and March 2019. A blinded radiologist measured T2-weighted signal intensity (SI) ratio (SI
/SI
), T2-weighted histogram features, and chemical shift SI index. Two blinded radiologists (radiologist 1 and radiologist 2) assessed T2-weighted SI and T2-weighted heterogeneity using five-point Likert scales.
Subjectively, T2-weighted SI (
< .001 for radiologist 1 and radiologist 2) and T2-weighted heterogeneity (
< .001, for radiologist 1 and radiologist 2) were higher in metastases compared with adenomas when assessed by both radiologists. Agreement between the radiologists was substantial for T2-weighted SI (Cohen κ = 0.67) and T2-weighted heterogeneity (κ = 0.62). Metastases had higher T2-weighted SI ratio than adenomas (3.6 ± 1.7 [95% confidence interval {CI}: 0.2, 8.2] vs 2.2 ± 1.0 [95% CI: 0.6, 4.3],
< .001) and higher T2-weighted entropy (6.6 ± 0.6 [95% CI: 4.9, 7.5] vs 5.0 ± 0.8 [95% CI: 3.5, 6.6],
< .001). At multivariate analysis, T2-weighted entropy was the best differentiating feature (
<
001). Chemical shift SI index did not differ between metastases and adenomas (
= .748). Area under the receiver operating characteristic curve (AUC) for T2-weighted SI ratio and T2-weighted entropy were 0.76 (95% CI: 0.64, 0.88) and 0.94 (95% CI: 0.88, 0.99). The logistic regression model combining T2-weighted SI ratio with T2-weighted entropy yielded AUC of 0.95 (95% CI: 0.91, 0.99) and did not differ compared with T2-weighted entropy alone (
= .268). There was no difference in logistic regression model accuracy comparing the data by either field strength, 1.5- or 3-T MRI (
> .05).
Logistic regression models combining T2-weighted SI and T2-weighted heterogeneity can differentiate metastases from lipid-poor adenomas. Validation of these preliminary results is required.
Adrenal, MR-Imaging, Urinary
© RSNA, 2020.</abstract><cop>United States</cop><pub>Radiological Society of North America</pub><pmid>33778748</pmid><doi>10.1148/rycan.2020200011</doi><orcidid>https://orcid.org/0000-0002-2653-4786</orcidid><orcidid>https://orcid.org/0000-0002-9442-7536</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2638-616X |
ispartof | Radiology. Imaging cancer, 2020-11, Vol.2 (6), p.e200011-e200011 |
issn | 2638-616X 2638-616X |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7983803 |
source | Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central |
subjects | Original Research |
title | Utility of T2-weighted MRI to Differentiate Adrenal Metastases from Lipid-Poor Adrenal Adenomas |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T06%3A32%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Utility%20of%20T2-weighted%20MRI%20to%20Differentiate%20Adrenal%20Metastases%20from%20Lipid-Poor%20Adrenal%20Adenomas&rft.jtitle=Radiology.%20Imaging%20cancer&rft.au=Tu,%20Wendy&rft.date=2020-11-01&rft.volume=2&rft.issue=6&rft.spage=e200011&rft.epage=e200011&rft.pages=e200011-e200011&rft.issn=2638-616X&rft.eissn=2638-616X&rft_id=info:doi/10.1148/rycan.2020200011&rft_dat=%3Cproquest_pubme%3E2506513165%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2506513165&rft_id=info:pmid/33778748&rfr_iscdi=true |